£795.00

The 2023-2028 World Outlook for Exosomes

Subjects

Price data last checked 25 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 66 days · 66 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 66 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (66 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 66 days

Description

This study covers the world outlook for exosomes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of exosomes as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include BioCat, BioVision, Danaher, Diagenode, Fujifilm, Hitachi Chemical Diagnostics, Illumina, Lonza Group, Malvern Instruments, MBL International, Miltenyi Biotec, New England Peptide, Novus Biologicals, Qiagen, Takara Bio, and Thermo Fisher Scientific. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09XZGV1QN
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 05 May 2022

The 2023-2028 World Outlook for Exosomes

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 World Outlook for Exosome Industries

The 2023-2028 World Outlook for Exosome Therapeutics

The 2025-2030 World Outlook for Exosomes

The 2025-2030 World Outlook for Exosome Industries

The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics

The 2025-2030 World Outlook for Exosome Therapeutics

The 2026-2031 World Outlook for Exosomes

Exosomes - Recent Advances From Bench to Bedside: 20 (Physiology)

Exosome Therapies: From Bench to Bedside in Chronic Disease

Stem Cell-Derived Exosomes and Microvesicles: Clinical Applications (Stem Cells in Clinical Applications)

The 2023-2028 World Outlook for Smart Exoskeletons

The 2026-2031 World Outlook for Exoskeletons

The 2023-2028 World Outlook for Medical Exoskeletons

Exosomes in Cardiovascular Diseases: Biomarkers, Pathological and Therapeutic Effects: 998 (Advances in Experimental Medicine and Biology, 998)

Unlocking the Secrets of Extracellular Vesicles and Exosomes: A Journey into the Cutting-Edge Frontier of Cellular Communication

The 2026-2031 World Outlook for Medical Exoskeletons

The 2026-2031 World Outlook for Smart Exoskeletons

The 2026-2031 World Outlook for Adult Stem Cell Research

Global Exosome Trials

The 2021-2026 World Outlook for Mesenchymal Stem Cells (MSC)

The 2016-2021 Outlook for Epigenetic Technologies in Greater China

Exosomes and MicroRNAs in Biomedical Science (Synthesis Lectures on Biomedical Engineering)

The 2023-2028 World Outlook for Whole Exome Sequencing Systems

The 2026-2031 World Outlook for 0-30 Micron PMMA Microspheres